Analyst Ratings for Fulcrum Therapeutics (FULC)
FULC Rating Summary
FULC Price Target Summary
- Highest: $15.00 (Oppenheimer)
- Lowest: $3.00 (H.C. Wainwright)
- Average: $7.11
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$7.11 (+92.2%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
Avg. $ Target:
$7.11 (+92.2%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/2/2026 | JPMorgan | N/A | Downgrade | Underweight (Overweight) |
N/A (N/A) |
6.42 (3.70) |
-42.37% | Details |
| 6/2/2026 | H.C. Wainwright | Andrew Fein | Downgrade | Neutral (Buy) |
3.00 (25.00) |
6.42 (3.70) |
-42.37% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
